July 18th 2016

July 18, 2016

Internet Enterpreneur Michael Greve Commits $10 Million 

to SENS-Related Research and Startups 

Including A $5 Million Donation Over 5 Years to SENS Research Foundation

$5 Million To Be Invested in Rejuvenation Biotechnology Related Startups

 

MOUNTAIN VIEW, Calif. — July 12, 2016 — German Internet Entrepreneur Michael Greve today announced that his Forever Healthy Foundation will be committing $5 Million in philanthropic support over the next five years to the SENS Research Foundation (SRF), a non-profit organization focused on transforming the way the world researches and treats age-related disease. In addition Michael Greve’s company KIZOO Technology Ventures will be committing seed investments of $5 million in startups focused on bringing rejuvenation biotechnology treatments to market.

 

“My goal is to provide support for the critical research of the SENS Research Foundation and to facilitate the development of the rejuvenation biotech industry and ecosystem. I think we should have more people contribute to the step-by-step creation of cures for the root causes of all age-related diseases. And we should have a whole rejuvenation industry based on the SENS treatment model including the self-accelerating feedback-loop of success stories and amazing opportunities for scientist, entrepreneurs and VC investors. This will truly accelerate both research and therapies. I have decided to lead by example and make this $10 million commitment,” said Michael Greve.

 

Forever Healthy Foundation’s initial donation will fund projects including Allotopic Expression of Mitochondrial Genes led by Dr. Matthew O’Connor at the SENS Research Foundation Research center and Pharmacological and/or enzymatic cleavage of glucosepane crosslinks led by Dr. David Spiegel at Yale University, SENS Research Foundation’s Education Program led by Dr. Greg Chin and other SENS Research Foundation programs.

 

“Michael Greve’s commitment shows that there is clear support for the critical work of the SENS Research Foundation.  As the first donation in our Project|21 fundraising campaign, it will help enable us to build a bridge to the first human clinical trials of Rejuvenation Biotechnologies by 2021. This gift is an important cornerstone that we will be able to build upon,” said Mike Kope, CEO, SENS Research Foundation.

 

For more information on the SENS Research Foundation visit our website. For information on Project|21, go here. And for information on Michael Greve go visit kizoo and Forever Healthy.

 

SENS Research Foundation Announces $50 Million Project|21 Campaign

Campaign Focus:  Ending Aging

 

MOUNTAIN VIEW, Calif. — July 12, 2016 — SENS Research Foundation today announced its Project|21 campaign to secure $50 million in private support from individual donors, foundations, and corporations. The goal of Project|21 is for SRF to partner with a new generation of visionary philanthropists, build the Rejuvenation Biotechnology industry, and bridge the most challenging gulf between research and treatment by enabling human clinical trials by 2021.

 

Aubrey de Grey, founder and chief science officer of SENS Research Foundation said, “Ending aging will require large-scale investment to flow into a globally-recognized industry for rejuvenation biotechnology. Since we began in 2009, SENS Research Foundation has been putting all the pieces in place – core research groups, key players, shared knowledge, underlying tools—for the creation of this industry. The key programs funded by Project|21 can create an environment where the first damage repair interventions addressing specific age-related diseases will be brought to human clinical trials within five years.”

 

The programs funded under Project|21 focus on three major barriers to the development of truly effective rejuvenation therapies. First, funding to convert promising basic research programs into solid investment candidates remains far too scarce. Second, there are too few opportunities for dynamic collaborations with mainstream regenerative medicine. Finally, there is little understanding of the regulatory pathways and clinical infrastructure these technologies will require. Project|21 addresses these three areas by creating a $15 million bridge fund to support promising early stage technologies; a center of excellence to deliver better opportunities for collaborative development of early stage programs; and a Rejuvenation Biotechnology Alliance Program to address challenges in regulation, manufacturing, and investment.

 

The first donation received for Project|21 is a commitment from German internet entrepreneur Michael Greve’s Forever Healthy Foundation for $5 Million in philanthropic support over the next five years. In addition Michael Greve’s company KIZOO Technology Ventures will be committing seed investments of $5 million in startups focused on bringing rejuvenation biotechnology treatments to market.

Can We Reach $60,000 for "Control ALT, Delete Cancer"

With Just One Month To Go?

That's Up To You.

Our OncoSENS program depends on the generosity of supporters like you in order to maintain critical laboratory resources and enable this groundbreaking work toward ending cancer to continue. We are grateful to everyone who has donated so far. With only a month to go in the campaign, we're facing quite a challenge -- please don't delay in making your contribution (and tell your friends)!

Ask Aubrey de Grey and Haroldo Silva Anything on Reddit Tomorrow

 

SRF Chief Science Officer Aubrey de Grey and OncoSENS lead researcher Haroldo Silva will be answering your questions about our quest to 'Control ALT, Delete Cancer' tomorrow (Tuesday, July 19). Make sure you save this link and come prepared with questions at 1 PM Eastern Standard Time / 10 AM Pacific / 6 PM BST.

 

 

Reminder: Rejuvenation Biology 2016 is Live Streaming!

On August 16-17, SENS Research Foundation will be live streaming this year's Rejuvenation Biotechnology conference so that everyone interested in getting the real-time experience of our speaker presentations can do so from anywhere.

 

Make sure you stay in the loop by filling out the brochure request form on our website in order to receive important details about accessing the live stream as soon as they are available. And don't forget to mark your calendars for August 16-17, 2016!

 

 

Want to help spread the word about SRF's mission?

Share our vision to Reimagine Aging on

 

   Facebook       @SENSTweet

Please show your support for SRF's work - Donate Today.

As a 501(c)(3) public charity, SENS Research Foundation relies on your support

to continue our mission to change the way the world researches and treats age-related disease.

 

 

Visit our donate page to make your contribution.

 

Want your Amazon purchases to help fight age-related disease?

When you shop at AmazonSmile, Amazon donates 0.5% of the purchase price to SENS Research Foundation. Bookmark this link and support us every time you shop!